DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis

BACKGROUND: In vitro fertilization (IVF) patients receive various adjuvant therapies to enhance success rates, but the true benefit is actively debated. Growth hormone (GH) and dehydroepiandrosterone (DHEA) supplementation were assessed in women undergoing fresh IVF transfer cycles and categorized a...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Kevin N., Hinchliffe, Peter M., Rowlands, Philip K., Borude, Gayatri, Srinivasan, Shanti, Dhaliwal, Satvinder S., Yovich, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797762/
https://www.ncbi.nlm.nih.gov/pubmed/29445356
http://dx.doi.org/10.3389/fendo.2018.00014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797762/
https://www.ncbi.nlm.nih.gov/pubmed/29445356
http://dx.doi.org/10.3389/fendo.2018.00014

Ejemplares similares